The development of novel drugs: the role of lyophilization
As the pharmaceutical industry focuses on complex, potentially life changing biologics, lyophilization, or freeze-drying, has become essential for the successful…
Partner Content
-
-
Gamma delta T cells explained: The next medical breakthrough?
Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than…
-
Pharma cold chains: Major trends shaping the next decade
The pharmaceutical industry is on the brink of a remarkable transformation over the next ten years. As the demand for…
-
The fundamentals of developing parenteral drug products
A target product profile (TPP) is a set of necessary attributes that the final drug product must have for the…
-
The people-first approach transforming eClinical processes
As data management applications become more commonplace across the clinical sphere, and teams search for new ways to use technology…
-
Cervical cancer: Navigating today’s global clinical trial landscape
A new report from leading contract research organisation Novotech has shed light on the current state of play in the…
-
How hybrid models and tech are shaping the future of clinical research
The world of clinical trials is undergoing a rapid change. Today, the rise of decentralized clinical trials (DCTs) and hybrid…
-
Debunking five misconceptions about community-based research sites in clinical trials
Clinical trials often face significant challenges in recruiting and retaining diverse participants, which can lead to skewed data and less…
-
Futureproofing supply chains in an evolving pharmaceutical industry
Pharmaceutical supply chains are some of the world’s most intricate. Recent developments have only heightened the challenges for companies on…
-
Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay
Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to…